UK markets closed

ArriVent BioPharma, Inc. (AVBP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
20.10-0.05 (-0.25%)
At close: 04:00PM EDT
20.10 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
Total revenue
0
0
0
Operating expenses
Research development
71,623
64,884
30,433
Selling general and administrative
11,469
9,706
6,473
Total operating expenses
83,092
74,590
36,906
Operating income or loss
-83,092
-74,590
-36,906
Income before tax
-74,578
-69,333
-36,906
Income from continuing operations
-74,578
-69,333
-36,906
Net income
-74,578
-69,333
-36,906
Net income available to common shareholders
-74,578
-69,333
-36,906
Basic EPS
-1.83
-2.17
-1.15
Diluted EPS
-1.83
-2.17
-1.15
Basic average shares
31,957
31,957
31,957
Diluted average shares
31,957
31,957
31,957